The ADMIRE Network, funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) aims to strengthen international collaboration on ‘Strategies for therapeutic targeting of the Aldosterone-Mineralocorticoid Receptor signaling pathway’.
The ADMIRE network consists of a core group of 20 researchers from 6 European countries, covering a broad spectrum of research areas from molecular biology, epigenetics, immunology, translational and clinical medicine, to pharmacology and chemical biology. Together, they evaluate potential new indications and explore innovative approaches for therapeutic targeting of the Aldosterone-Mineralocorticoid Receptor signaling pathway. The present initiative builds on the previous EU COST action ADMIRE and serves as an open forum for all researchers interested in aldosterone, the mineralocorticoid receptor, or related topics.
Joint Symposium of the European Section of the Aldosterone Council (ESAC) and the ADMIRE Network
SAVE THE DATE: March 24-25, 2023, in Freiburg, Germany
more information coming soon
ADMIRE Network Virtual Forum – upcoming events
With this series we aim to strengthen the exchange between scientists worldwide. The forum is open to everybody who is interested upon registration. Please forward the invitation to your colleagues and staff and help make this an exciting event.
January 2023 | Mineralocorticoid receptors, depression & cardiovascular risk
Christian Otte, Department of Psychiatry and Neurosciences, Charité Universitätsmedizin Berlin, Germany,
Johannes Backs, Institute of Experimental Cardiology, University of Heidelberg, Germany
January 18, 2023, 4 pm CET | please register here
December 2022 | Non-canonical and other novel MR signalling mechanisms in the heart
Morag Young, Baker Heart and Diabetes Institute, Melbourne, Australia
December 15, 2022, 1pm CET | please register here
November 2022 | Cardiorenal Protection by Non-Steroidal Mineralocorticoid Receptor Antagonists
Ulrich Kintscher, Institute of Pharmacology, Charité Universitätsmedizin Berlin, Germany
November 16, 2022, 4 pm CET
October 2022 | Aldosterone-Mineralocorticoid Receptor Pathway in Heart Valve Disease
Natalia López-Andrés, Translational Cardiology, Navarrabiomed, Spain
October 26, 2022, 4 pm CET | watch video (code: c051xjpRi)
The ADMIRE Network organized a themed issue of the British Journal of Pharmacology entitled
Emerging Fields for Therapeutic Targeting of the Aldosterone-Mineralocorticoid Receptor Signaling Pathway
Edited by: Achim Lother, Ulrich Wenzel, Frédéric Jaisser
Br J Pharmacol. 2022;179(13):3235-3249.